| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2079 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1495 | 2018 |
| Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity S Leclercq, S Matamoros, PD Cani, AM Neyrinck, F Jamar, P Stärkel, ... Proceedings of the National Academy of Sciences 111 (42), E4485-E4493, 2014 | 842 | 2014 |
| Enteric dysbiosis associated with a mouse model of alcoholic liver disease AW Yan, D E. Fouts, J Brandl, P Stärkel, M Torralba, E Schott, ... Hepatology 53 (1), 96-105, 2011 | 828 | 2011 |
| Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease YI Duan, C Llorente, S Lang, K Brandl, H Chu, LU Jiang, RC White, ... Nature 575 (7783), 505-511, 2019 | 567 | 2019 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 559 | 2014 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 413 | 2014 |
| Intestinal fungi contribute to development of alcoholic liver disease AM Yang, T Inamine, K Hochrath, P Chen, L Wang, C Llorente, S Bluemel, ... The Journal of clinical investigation 127 (7), 2829-2841, 2017 | 398 | 2017 |
| Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation L Wang, DE Fouts, P Stärkel, P Hartmann, P Chen, C Llorente, J DePew, ... Cell host & microbe 19 (2), 227-239, 2016 | 334 | 2016 |
| Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice P Chen, M Torralba, J Tan, M Embree, K Zengler, P Stärkel, ... Gastroenterology 148 (1), 203-214. e16, 2015 | 311 | 2015 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017 | 308 | 2017 |
| Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice P Chen, P Stärkel, JR Turner, SB Ho, B Schnabl Hepatology 61 (3), 883-894, 2015 | 300 | 2015 |
| Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects S Leclercq, PD Cani, AM Neyrinck, P Stärkel, F Jamar, M Mikolajczak, ... Brain, behavior, and immunity 26 (6), 911-918, 2012 | 297 | 2012 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 273 | 2014 |
| SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule A Werion, L Belkhir, M Perrot, G Schmit, S Aydin, Z Chen, A Penaloza, ... Kidney international 98 (5), 1296-1307, 2020 | 269 | 2020 |
| The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications B Delire, P Stärkel European journal of clinical investigation 45 (6), 609-623, 2015 | 254 | 2015 |
| Deficiency of intestinal mucin‐2 ameliorates experimental alcoholic liver disease in mice P Hartmann, P Chen, HJ Wang, L Wang, DF McCole, K Brandl, P Stärkel, ... Hepatology 58 (1), 108-119, 2013 | 245 | 2013 |
| Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice P Hartmann, K Hochrath, A Horvath, P Chen, CT Seebauer, C Llorente, ... Hepatology 67 (6), 2150-2166, 2018 | 232 | 2018 |
| Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice T Hendrikx, YI Duan, Y Wang, JH Oh, LM Alexander, W Huang, P Stärkel, ... Gut 68 (8), 1504-1515, 2019 | 229 | 2019 |
| Animal models for the study of hepatic fibrosis P Starkel, IA Leclercq Best practice & research Clinical gastroenterology 25 (2), 319-333, 2011 | 228 | 2011 |
